The Biggest Psychedelic News This Week: November 6 – 10 | Psychedelic Spotlight

As researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization efforts. However, the space also sees reprimands for abuse by therapists and a pilot attributing almost shutting off plane engines to a “nervous breakdown” caused by shrooms.

Immunic Highlights 2023 Accomplishments and Upcoming Milestones – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Miscellaneous/Financing 05.01.2024 / 12:35 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Highlights 2023

January 6, 2024

Updated: GSK takes victory lap with blockbuster sales for RSV vaccine

GSK is looking to ride the momentum from its RSV vaccine sales into 2024 and beyond. Meanwhile, it has cut three infectious disease candidates from

February 1, 2024

Can a Common Diabetes Drug Turn Patients’ Urine Into Alcohol?

One patient had multiple false positive toxicology tests after taking a popular diabetes drug. Despite not ingesting alcohol for over 10 months, a man in

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.